This week's issue of "The Tan Sheet" features a story on congressional demands that FDA release an existing supply of OTC asthma inhaler Primatene Mist. We've got a look at the Center for Reproductive Rights' revised lawsuit on the Plan B emergency contraceptive, as well as a story on supplement sales trends for 2012.
There's also insight into the quarterly earnings reports of Perrigo, Reckitt Benckiser, Dr. Reddy's Laboratories, Church & Dwight and more.
Click here for a full table of contents from our Feb. 13 issue.
"The Tan Sheet" is your source for the most comprehensive and in-depth coverage of the OTC drug and nutritional industries. Start your free trial subscription here -- no credit card required.
Also, follow "The Tan Sheet" on Twitter and Facebook.
- Dan Schiff (d.schiff@elsevier.com)
